These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19491816)

  • 1. [Results of a study of velaxin (venlafaxine) efficacy in patients with subacute and chronic spondylogenic dorsalgia].
    Batysheva TT; Kamchatnov PR; Guseva ME; Zaĭtsev KA; Zhuravleva EIu; Kostenko EV; Nesterova OS; Otcheskaia OV; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):32-5. PubMed ID: 19491816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.
    Bradley RH; Barkin RL; Jerome J; DeYoung K; Dodge CW
    Am J Ther; 2003; 10(5):318-23. PubMed ID: 12975715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Velaxin (venlafaxine) in the treatment of anxious depression].
    Il'ina NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):24-8. PubMed ID: 18427537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine hydrochloride and chronic pain.
    Taylor K; Rowbotham MC
    West J Med; 1996 Sep; 165(3):147-8. PubMed ID: 8909172
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience of the use of velaxin (venlafaxine) in anxious depression.
    Il'ina NA
    Neurosci Behav Physiol; 2009 Mar; 39(3):305-9. PubMed ID: 19234798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].
    Rachin AP; Sergeev AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):68-70. PubMed ID: 19938277
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study.
    Dias RS; Kerr-Corrêa F; Moreno RA; Trinca LA; Pontes A; Halbe HW; Gianfaldoni A; Dalben IS
    Menopause; 2006; 13(2):202-11. PubMed ID: 16645534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
    Ivanets NN; Kinkulkina MA; Tikhonova YG; Iziumina TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):30-34. PubMed ID: 25909786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of venlafaxine extended release formulation on the clinical management of patients].
    Carrasco JL; Díaz-Marsá M; López-Ibor JJ
    Actas Esp Psiquiatr; 2005; 33(3):147-53. PubMed ID: 15918081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
    Einarson TR; Arikian SR; Casciano J; Doyle JJ
    Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
    Feighner JP; Entsuah AR; McPherson MK
    J Affect Disord; 1998 Jan; 47(1-3):55-62. PubMed ID: 9476744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.
    Enggaard TP; Klitgaard NA; Gram LF; Arendt-Nielsen L; Sindrup SH
    Clin Pharmacol Ther; 2001 Apr; 69(4):245-51. PubMed ID: 11309553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related paresthesias with venlafaxine.
    Angelo LJ; Lee KC
    J Pharm Pract; 2013 Oct; 26(5):514-7. PubMed ID: 23764565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial.
    Forssell H; Tasmuth T; Tenovuo O; Hampf G; Kalso E
    J Orofac Pain; 2004; 18(2):131-7. PubMed ID: 15250433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.
    Smith D; Dempster C; Glanville J; Freemantle N; Anderson I
    Br J Psychiatry; 2002 May; 180():396-404. PubMed ID: 11983635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.